2023·01·12
Guantao Law Firm advises Qingdao Military-Civilian Integration Development Group on restructuring Ta
Guantao Law Firm advises Qingdao Military-Civilian Integration Development Group on restructuring TaGuantao Law Firm advises Qingdao Military-Civilian Integration Development Group on restructuring Taihai Manoir Nuclear Equipment Co., Ltd. and its wholly owned subsidiariesOn 23 December 2022, the People’s Court of Laishan District, Yantai City, Shandong Province ruled that the restructuring plan of Taihai Manoir Nuclear Equipment Co., Ltd. (“Taihai Nucle...
2023·01·12
Guantao Law Firm advises Beijing Building Materials Testing Academy Co., Ltd. get listing and share
Guantao Law Firm advises Beijing Building Materials Testing Academy Co., Ltd. get listing and share Guantao Law Firm advises Beijing Building Materials Testing Academy Co., Ltd. get listing and share transfer at the National Equities Exchange and Quotations Beijing Building Materials Testing Academy Co., Ltd. (herein after referred to as BMT) is the one of leaders for third-party quality inspection, testing and certification services in China. Centering on the qual...
2023·01·09
Guantao Law Firm advises with the approval for the first 2 billion yuan shelf registration of ABS in
Guantao Law Firm advises with the approval for the first 2 billion yuan shelf registration of ABS inGuantao Law Firm advises with the approval for the first 2 billion yuan shelf registration of ABS in Yancheng, and Yancheng Port Holding Group’s issuance of 2023 Phase I Super & Short-term Commercial Paper On 29 December 2022, Guantao Law Firm advised Jiangsu Yancheng Port Supply Chain Technology Group Co., Ltd. (“Yancheng Port Supply Chain Group”) ...
2023·06·16
Guantao Law Firm advises Nanjing Baose Co., Ltd. gain the approval of issuing shares to specific obj
Guantao Law Firm advises Nanjing Baose Co., Ltd. gain the approval of issuing shares to specific objGuantao Law Firm advises Nanjing Baose Co., Ltd. gain the approval of issuing shares to specific objects from China Securities Regulatory CommissionGuantao Law Firm helped the issuer, Nanjing Baose Co., Ltd. (“Baose”), gain the approval for issuing shares to specific objects by China Securities Regulatory Commission on 31 May 2023. Baose is a high-tech enterpri...
2019·12·16
Guantao assisted Zhongce Rubber Group Co., Ltd. in completing the transfer of controlling stakes
Guantao assisted Zhongce Rubber Group Co., Ltd. in completing the transfer of controlling stakesOn October 21, 2019, Hangzhou Zhongce Haichao Enterprise Management Co., Ltd. completed the acquisition of 46.95% equity of Zhongce Rubber Group Co.,Ltd., which involved the listed companies Hangzhou Great Star Technology Co., Ltd. (stock code: 002444) and Hangcha Group Co., Ltd. (stock code: 603298 ). On October 25, 2019, Shanghai Tongzhong Enterprise Managemen...
2019·12·02
Guantao advised China Aluminum International Engineering Corporation Limited on its issuance of USD
Guantao advised China Aluminum International Engineering Corporation Limited on its issuance of USD On 21 November 2019, China Aluminum International Engineering Corporation Limited (601068.SH、2068.HK) (the 'Company') issued USD 350 million perpetual capital securities in Hong Kong by Chalieco Hong Kong Corporation Limited (the “Issuer”), which is a wholly-owned subsidiary of the Company.The Company is a leading technology, engineering serv...
2019·09·17
Guantao advised Aluminum Corporation of China on its issuance of USD750 million perpetual securities
Guantao advised Aluminum Corporation of China on its issuance of USD750 million perpetual securitiesOn 11 September 2019, Aluminum Corporation of China(the 'Company')issued USD 750 million perpetual securities in Hong Kong.The Company is a key state-owned enterprise directly supervised by the State-owned Assets Supervision and Administration Commission of the State Council. According to Fortune Magazine, the Company has been a Fortune Global...
2019·07·23
Guantao Advised CASI Pharmaceuticals, Inc. (Nasdaq: CASI) on its At-the-Market Offering
Guantao Advised CASI Pharmaceuticals, Inc. (Nasdaq: CASI) on its At-the-Market OfferingEastern Time (US & Canada) July 19, 2019, CASI Pharmaceuticals, Inc. (Nasdaq: CASI) entered into an Open Market Sale AgreementSM with Jefferies LLC. Pursuant to the terms of the Sales Agreement, CASI may elect to sell from time to time, at its option, up to $30 million shares of its common stock through Jefferies LLC, as sales agent by any method ...